Immune-Mediated Haemolytic Anaemia (IMHA)
A life-threatening disease in which the immune system destroys red blood cells, causing severe anaemia and a high risk of blood clots.
Overview
IMHA is primary (idiopathic) in most dogs, with Cocker Spaniels and other breeds predisposed, and secondary to infections, drugs or cancer in others. In cats, primary IMHA also appears to be more common, but secondary causes (such as Mycoplasma haemofelis or FeLV) must be ruled out. Thromboembolism is a leading cause of death in dogs.
Clinical signs
- Pale or yellow gums
- Weakness, lethargy and collapse
- Fast breathing and heart rate
- Dark red or orange urine
Diagnosis
- Low PCV with regenerative anaemia
- Spherocytes and autoagglutination on a blood smear
- Direct antiglobulin (Coombs) test
- Screening for infections, drugs and cancer
Treatment
- Immunosuppression with corticosteroids and a second agent (such as mycophenolate, azathioprine or ciclosporin)
- Blood transfusions
- Thromboprophylaxis (clopidogrel, rivaroxaban or heparin)
Prognosis
Guarded. Many dogs die in the first few weeks, but those surviving the initial phase often do well.
This page is general reference information for educational purposes. It is not a substitute for an individual clinical assessment, current formulary guidance, or the judgment of a licensed veterinarian treating a specific patient.
Frequently asked questions
Why does my pet need blood thinners?
IMHA greatly increases the risk of blood clots, which can be fatal.
Can IMHA come back?
Yes, relapses can occur, especially when tapering medication.